Identification of an Immune-Related Biomarker Model Based on the CircRNA-Associated Regulatory Network for Esophageal Carcinoma

Figure 6

Immune landscape of ESCA patients. (a) The proportion of infiltrative immune cells in two risk groups. (b) The correlation of the risk score with CD8⁺ T cells, plasma cells, M0 macrophages, activated NK cells, and resting memory CD4⁺ T cells.

(a)

(b)